Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2

Known as: APVAC2 
A personalized peptide-based cancer vaccine comprised of one or two de novo synthesized patient-specific tumor-mutated peptides associated with… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cancer immunotherapy to gliomas has so far failed to show encouraging results, as gliomas are rarely mutated and show various… Expand
Is this relevant?
Highly Cited
2018
Highly Cited
2018
Patients with glioblastoma currently do not sufficiently benefit from recent breakthroughs in cancer treatment that use… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2016
2016
The Glioma Actively Personalized Vaccine Consortium (GAPVAC; funded by the European Union Framework 7 Program) aims at treating… Expand
Is this relevant?